Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350870 · ClinicalTrials.gov registry record · Phase 1
CBT With Disulfiram and Contingency Management
A Phase 1 study of Cocaine Abuse, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 181
- Enrollment target
- 1
- Study location
NCT00350870 is a Phase 1 study of Cocaine Abuse that has completed, run by Yale University. The registered enrollment target is 181 participants, below the 899-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00350870, a Phase 1 study of Cocaine Abuse, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 181 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG disulfiram
- BEHAVIORAL Placebo plus Contingency Management
- DRUG Disulfiram plus Contingency Management
Study Locations (1)
Connecticut
- APT Foundation - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2005-04 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350870
The ClinicalTrials.gov registry entry for NCT00350870 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 899-participant average among 9 other Cocaine Abuse trials with a reported enrollment target (80% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Abuse appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT00350870 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00350870 about?
NCT00350870 is a clinical study titled "CBT With Disulfiram and Contingency Management". This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use. All participants will receive weekly individual cognitive behavioral therapy (CBT).
What is the current status of trial NCT00350870?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 181 participants. The study started on 2005-04. Estimated completion is 2010-12.
What conditions does trial NCT00350870 study?
This clinical trial studies the following conditions: Cocaine Abuse.
What interventions are being tested in trial NCT00350870?
The interventions under investigation include: Placebo (DRUG), disulfiram (DRUG), Placebo plus Contingency Management (BEHAVIORAL), Disulfiram plus Contingency Management (DRUG).
Who is sponsoring clinical trial NCT00350870?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00350870 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin
COMPLETED · Phase 1
-
Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
COMPLETED · Phase 1
-
Long Term Maintenance of Drug Abstinence
COMPLETED · Phase 1
-
Substance Abuse Pre-Treatment Screening Study
RECRUITING
-
Progesterone for the Treatment of Cocaine Dependence - 1
COMPLETED · NA
-
Effects of Aripiprazole on Cocaine Craving and Self-Administration
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.